Incidence of Intravascular (IV) Injection During Trigeminal Nerve Blocks

Last updated: August 3, 2023
Sponsor: Seoul National University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Trigeminal Neuralgia

Migraine (Pediatric)

Headaches

Treatment

trigeminal nerve block

Clinical Study ID

NCT04467398
2004-207-1120
  • Ages 19-85
  • All Genders

Study Summary

The purpose of this study is to investigate the incidence of intravascular injection during trigeminal nerve blocks.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • The patients who scheduled to undergo trigeminal nerve block due to the facial pain

Exclusion

Exclusion Criteria:

  • Refusal of the patient
  • Pregnancy
  • Coagulopathy
  • Local or systemic infection
  • Allergy to injectate
  • Anatomical deformation of the skull

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: trigeminal nerve block
Phase:
Study Start date:
July 20, 2020
Estimated Completion Date:
June 15, 2024

Study Description

The patients who already scheduled for trigeminal nerve blocks will be randomized in a 1:1 ratio to tuohy needle group or quincke needle group after being informed about the study.

Connect with a study center

  • Seoul National University Hospital

    Seoul,
    Korea, Republic of

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.